Muscle Oxidative Capacity Is a Better Predictor of Insulin Sensitivity than Lipid Status
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
We determined whole-body insulin sensitivity, long-chain fatty acyl coenzyme A (LCACoA) content, skeletal muscle triglyceride (TGm) concentration, fatty acid transporter protein content, and oxidative enzyme activity in eight patients with type 2 diabetes (TYPE 2); six healthy control subjects matched for age (OLD), body mass index, percentage of body fat, and maximum pulmonary O2 uptake; nine well-trained athletes (TRAINED); and four age-matched controls (YOUNG). Muscle biopsies from the vastus lateralis were taken before and after a 2-h euglycemic-hyperinsulinemic clamp. Oxidative enzyme activities, fatty acid transporters (FAT/CD36 and FABPpm), and TGm were measured from basal muscle samples, and total LCACoA content was determined before and after insulin stimulation. Whole-body insulin-stimulated glucose uptake was lower in TYPE 2 (P < 0.05) than in OLD, YOUNG, and TRAINED. TGm was elevated in TYPE 2 compared with all other groups (P < 0.05). However, both basal and insulin-stimulated skeletal muscle LCACoA content were similar. Basal citrate synthase activity was higher in TRAINED (P < 0.01), whereas β-hydroxyacyl CoA dehydrogenase activity was higher in TRAINED compared with TYPE 2 and OLD. There was a significant relationship between the oxidative capacity of skeletal muscle and insulin sensitivity (citrate synthase, r = 0.71, P < 0.001; β-hydroxyacyl CoA dehydrogenase, r = 0.61, P = 0.001). No differences were found in FAT/CD36 protein content between groups. In contrast, FABPpm protein was lower in OLD compared with TYPE 2 and YOUNG (P < 0.05). In conclusion, despite markedly elevated skeletal muscle TGm in type 2 diabetic patients and strikingly different levels of whole-body glucose disposal, both basal and insulin-stimulated LCACoA content were similar across groups. Furthermore, skeletal muscle oxidative capacity was a better predictor of insulin sensitivity than either TGm concentration or long-chain fatty acyl CoA content.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The regeneration potential of muscle is impaired, which might promote fibrosis, thereby promoting insulin resistance76–79, partially owing to impaired mitochondrial fatty acid oxidation and increased lipolysis76,80.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [80]
In the citing paper
“Defects in skeletal muscle oxidative capacity and fat metabolism are highly correlated with insulin sensitivity (IS) (1,5,12) and are believed to contribute to the pathogenesis of insulin resistance (13,14).”
From Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor (2005) · cites this paper as [12]
In the citing paper
“Moreover, oxidative activity (e.g., citrate synthase, acyl CoA dehydrogenase) is a robust correlate of insulin sensitivity, even better than either im triglycerides or long-chain fatty acyl CoA (110).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [110]
In the citing paper
“Impaired flexibility also correlates with intramyocellular accumulation of lipids (107), and 24-h RQ can predict subsequent weight gain (110, 113).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [110]
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
A Flexible System of Enzymatic Analysis
(1972) · Elsevier eBooks · doi:10.1016/b978-0-12-457950-7.x5001-3 · Cited by 4,051
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Krssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264
Goodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194
Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179
Self-citationSkeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Self-citationKelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096
Perseghin, G., Scifo, P., De Cobelli, F., Pagliato, E., Battezzati, A., Arcelloni, C., Vanzulli, A., Testolin, G., Pozza, G., Del Maschio, A., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1600 · Cited by 877
Lemberger, T., Desvergne, B., & Wahli, W. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.335 · Cited by 712
Lipid oxidation is reduced in obese human skeletal muscle
Kim, J.-Y., Hickner, R. C., Cortright, R. L., Dohm, G. L., & Houmard, J. A. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1039 · Cited by 634
Development of Muscle Insulin Resistance After Liver Insulin Resistance in High-Fat–Fed Rats
Kraegen, E. W., Clark, P. W., Jenkins, A. B., Daley, E. A., Chisholm, D. J., & Storlien, L. H. (1991) · Diabetes · doi:10.2337/diab.40.11.1397 · Cited by 601
Schmitz-Peiffer, C., Craig, D. L., & Biden, T. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24202 · Cited by 592
He, J., Watkins, S., & Kelley, D. E. (2001) · Diabetes · doi:10.2337/diabetes.50.4.817 · Cited by 518
Simoneau, J., Veerkamp, J. H., Turcotte, L. P., & Kelley, D. E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2051 · Cited by 491
Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
Kelley, D. E., & Simoneau, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117600 · Cited by 487
Summers, S. A., Garza, L. A., Zhou, H., & Birnbaum, M. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5457 · Cited by 475
Simoneau, J.-A., & Kelley, D. E. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.166 · Cited by 441
Stein, D. T., Stevenson, B. E., Chester, M. W., Basit, M., Daniels, M. B., Turley, S. D., & McGarry, J. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119546 · Cited by 352
Membrane transport of long-chain fatty acids: evidence for a facilitated process
Abumrad, N., Harmon, C., & Ibrahimi, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33310-1 · Cited by 326
Schmitz-Peiffer, C., Browne, C. L., Oakes, N. D., Watkinson, A., Chisholm, D. J., Kraegen, E. W., & Biden, T. J. (1997) · Diabetes · doi:10.2337/diab.46.2.169 · Cited by 314
Gerbitz, K.-D., Gempel, K., & Brdiczka, D. (1996) · Diabetes · doi:10.2337/diab.45.2.113 · Cited by 296
Increased Rates of Fatty Acid Uptake and Plasmalemmal Fatty Acid Transporters in Obese Zucker Rats
Luiken, J. J. F. P., Arumugam, Y., Dyck, D. J., Bell, R. C., Pelsers, M. M. L., Turcotte, L. P., Tandon, N. N., Glatz, J. F. C., & Bonen, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100052200 · Cited by 282
Self-citationSignificance of skeletal muscle oxidative enzyme enhancement with endurance training.
Gollnick, P. D., & Saltin, B. (1982) · Clinical Physiology · doi:10.1111/j.1475-097x.1982.tb00001.x · Cited by 277
Ellis, B. A., Poynten, A., Lowy, A. J., Furler, S. M., Chisholm, D. J., Kraegen, E. W., & Cooney, G. J. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.3.e554 · Cited by 273
Self-citation1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo.
Turinsky, J., O'Sullivan, D. M., & Bayly, B. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44844-7 · Cited by 269
Forouhi, N. G., Jenkinson, G., Thomas, E. L., Mullick, S., Mierisova, S., Bhonsle, U., McKeigue, P. M., & Bell, J. D. (1999) · Diabetologia · doi:10.1007/s001250051250 · Cited by 242
Ravichandran, L. V., Esposito, D. L., Chen, J., & Quon, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007231200 · Cited by 217
Oakes, N. D., Bell, K. S., Furler, S. M., Camilleri, S., Saha, A. K., Ruderman, N. B., Chisholm, D. J., & Kraegen, E. W. (1997) · Diabetes · doi:10.2337/diab.46.12.2022 · Cited by 176
Houmard, J. A., Tanner, C. J., Yu, C., Cunningham, P. G., Pories, W. J., MacDonald, K. G., & Shulman, G. I. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2959 · Cited by 156
Antinozzi, P. A., Segall, L., Prentki, M., McGarry, J. D., & Newgard, C. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16146 · Cited by 149
Fatty acid profile of skeletal muscle phospholipids in trained and untrained young men
Andersson, A., Sjödin, A., Hedman, A., Olsson, R., & Vessby, B. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e744 · Cited by 139
Muscle Long‐Chain Acyl CoA Esters and Insulin Resistance
COONEY, G. J., THOMPSON, A. L., FURLER, S. M., YE, J., & KRAEGEN, E. W. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04276.x · Cited by 135
Self-citationThompson, A. L., & Cooney, G. J. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1761 · Cited by 131
Self-citationKraegen, E., Cooney, G., Ye, J.-M., Thompson, A., & Furler, S. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18581 · Cited by 130
Self-citationMechanism of palmityl coenzyme A inhibition of liver glycogen synthase.
Wititsuwannakul, D., & Kim, K. H. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41039-8 · Cited by 115
Muscle contraction increases palmitate esterification and oxidation and triacylglycerol oxidation
Dyck, D. J., & Bonen, A. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e888 · Cited by 89
Self-citationContractile Activity-Induced Mitochondrial Biogenesis in Skeletal Muscle
Essig, D. A. (1996) · Exercise and Sport Sciences Reviews · doi:10.1249/00003677-199600240-00012 · Cited by 55
Independent Influences of Central Fat and Skeletal Muscle Lipids on Insulin Sensitivity
Furler, S. M., Poynten, A. M., Kriketos, A. D., Lowy, A. J., Ellis, B. A., Maclean, E. L., Courtenay, B. G., Kraegen, E. W., Campbell, L. V., & Chisholm, D. J. (2001) · Obesity Research · doi:10.1038/oby.2001.70 · Cited by 53
Self-citationKriketos, A. D., Furler, S. M., Gan, S. K., Poynten, A. M., Chisholm, D. J., & Campbell, L. V. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020848 · Cited by 49
Self-citationFatty acid profile and cholesterol in skeletal muscle of trained and untrained men
Thomas, T. R., Londeree, B. R., Gerhardt, K. O., & Gehrke, C. W. (1977) · Journal of Applied Physiology · doi:10.1152/jappl.1977.43.4.709 · Cited by 35
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972
“The potential importance of CD36 in regulating insulin sensitivity is supported by studies conducted in animal models and in obese and diabetic human subjects that found increased plasmalemma skeletal muscle CD36 was associated with increased FFA uptake and insulin resistance (25, 30, 31) (even though total muscle CD3…”
ResultKalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Little, J. P., Gillen, J. B., Percival, M. E., Safdar, A., Tarnopolsky, M. A., Punthakee, Z., Jung, M. E., & Gibala, M. J. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00921.2011 · Cited by 787
“Since reduced mitochondrial capacity in skeletal muscle has been reported in insulin resistance and T2D (22) and muscle oxidative capacity has been shown to be a significant predictor of insulin sensitivity (3), it is possible that the rapid increase in skeletal muscle mitochondrial content following low-volume HIT ma…”
BackgroundLittle, J. P., Safdar, A., Wilkin, G. P., Tarnopolsky, M. A., & Gibala, M. J. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.181743 · Cited by 667
Metadata
- Authors
- Bruce, C. R., Anderson, M. J., Carey, A. L., Newman, D. G., Bonen, A., Kriketos, A. D., Cooney, G. J., & Hawley, J. A.
- Affiliations
- RMIT University (AU)
- The University of Melbourne (AU)
- Exercise Metabolism Group (C.R.B., D.G.N., J.A.H.), Victoria 3083, Australia
- University of Waterloo (CA)
- Garvan Institute of Medical Research (AU)
- Corresponding author
- Hawley, John A.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-11-01
- Volume
- 88
- Issue
- 11
- Pages
- 5444-5451
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2016194457
- Cited by
- 234
- References
- 43
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 10 · 2023: 5 · 2022: 3 · 2021: 7 · 2020: 8 · 2019: 9 · 2018: 7 · 2017: 11 · 2016: 4 · 2015: 7 · 2014: 14 · 2013: 14 · 2012: 16
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Swinburne figshare (Swinburne University of Technology) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin sensitivity, skeletal muscle oxidative capacity, type 2 diabetes, fatty acid transporters, FAT/CD36, FABPpm, citrate synthase, beta-hydroxyacyl-CoA dehydrogenase, insulin-stimulated glucose uptake, athletes, lipid status
- MeSH terms
- Fatty Acid-Binding Protein 7, Adult, Carrier Proteins, Diabetes Mellitus, Type 2, Female, Glucose, Humans, Insulin Resistance, Male, Membrane Glycoproteins, Middle Aged, Neoplasm Proteins, Predictive Value of Tests, Glucose Clamp Technique, Biomarkers, Body Mass Index, Oxidative Stress, Muscle, Skeletal, CD36 Antigens, Tumor Suppressor Proteins, Organic Anion Transporters, Lipid Metabolism, Fatty Acid-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.